3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
3
Breast Neoplasms
3
Rectal Neoplasms
2
Pain, Postoperative
2
Neurotoxicity Syndromes
2
Neoplasms
2
Colonic Neoplasms
2
Agnosia
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Supratentorial Brain Tumor
1
Stomach Neoplasms
1
Seizures
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Primary Immunodeficiency Diseases
1
Paclitaxel-induced Neuropathy
1
Myoma
1
Mesothelioma
1
Infections
1
Head and Neck Neoplasms
1
Epstein-Barr Virus Infections
1
Brain Neoplasms
1
Anesthesia
1
Interventions
X-Rays
2
Telemedicine
1
Sulfonylurea Compounds
1
Standard of Care
1
Sodium-Glucose Transporter 2 Inhibitors
1
Pulmonary Surgical Procedures
1
Palliative Care
1
Methods
1
Massage
1
Magnesium Sulfate
1
Lysine Acetyltransferase 5
1
Dipeptidyl-Peptidase IV Inhibitors
1
Cyclosporine
1
Calorimetry, Indirect
1
CIMAvax EGF
1
Bronchoscopy
1
Bronchoalveolar Lavage
1
Blood Specimen Collection
1
Behavior Therapy
1
Accelerometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pulmonary Disease, Chronic Obstructive
×
Magnesium Sulfate
×
Clear all
NCT03461328
2019-08-21
COPD
Cairo University
Phase 4
Completed
40 enrolled